Home | About Us | Our Products | Our Facilites | Quality Assurance | Feed Back | Contact Us
 

5th May 2009
Dolphin has added seven more formulations to its growing Sri Lanka Portfolio

28th April 2009
The Board of Directors of the Company in its 154th meeting held on Tuesday, 28 April, 2009 has recommended 50% cash and 25% stock dividend (bonus share)

Loratadine Tablet
Back
 a) Generic Name

Loratadine INN

 b) Trade/Brand Name

To be submitted at the time of inclusion.

 a) Presentation

Film Coated Tablet.
Each tablet contains Loratadine INN 10 mg.

 b) Indications

Seasonal allergic rhinitis, perennial allergic rhinitis, skin allergies including chronic urticaria.

 c) Dosage & administration

Adults and children over 30 kg of body weight, 10 mg once daily; children under 30 kg or under 5 years of age, 5 mg once daily; children under 2 years, not recommended.

 d) Contraindications

Hypersensitivity or idiosyncrasy to its components.

 e) Side Effects

Side effects of loratadine are generally mild. Fatigue, dizziness, dry mouth, headache, sedation, nausea and pruritus may be reported.

 f) Warnings & Precautions

Severe hepatic impairment alters the pharmacokinetics of loratadine and dose adjustment is required. Drowsiness can occur rarely and patients should be informed that it might affect skilled tasks.

 g) Drug Interactions

There are no reports of potentially hazardous interactions with other drugs.

 h) Use in Pregnancy & Lactation

The safe use of loratadine during pregnancy and lactation has not been established and therefore, this should be used only if the potential benefit justifies the potential risk to foetus.

 l) Package Quantity

To be submitted at the time of inclusion.


www.dolphinpharmaltd.com-Copyright © 2009 - All rights reserved. Designed by: www.linuxoptic.com